Aleynick, Nathaniel
Li, Yanyun
Xie, Yubin
Zhang, Mianlei
Posner, Andrew
Roshal, Lev http://orcid.org/0000-0002-7619-3465
Pe’er, Dana
Vanguri, Rami S.
Hollmann, Travis J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30-CA008748, P30-CA008748, P30-CA008748, P30-CA008748, P30-CA008748, P30-CA008748, U2C-CA233284, P30-CA008748, P30-CA008748, U2C-CA233284)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Parker Institute for Cancer Immunotherapy
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 5 October 2022
Accepted: 27 March 2023
First Online: 7 April 2023
Competing interests
: TJH received support from Parker Institute for Cancer Immunotherapy, and grants from Bristol Myers Squibb and Calico Labs during the conduct of the study.